In a multi-center, double-blind randomized trial across eight Dutch ICUs, 132 critically ill adults with delirium were administered intravenous haloperidol or placebo, resulting in no significant difference in delirium- and coma-free days. The study, which was terminated early for futility, also found haloperidol might decrease the need for benzodiazepines and reduce agitation-related behaviors, although these secondary outcomes were not statistically conclusive.
top of page
![](https://static.wixstatic.com/media/e4917c_6916dacbe9464ed19ee5fe4a43cdc4ed~mv2.png/v1/fill/w_940,h_240,fp_0.50_0.50,q_85,usm_0.66_1.00_0.01,enc_auto/e4917c_6916dacbe9464ed19ee5fe4a43cdc4ed~mv2.png)
General Critical Care
Public·640 members
bottom of page